Categories Earnings, Other Industries

Elliot Management bids for Athenahealth

Hedge fund Elliot Management Corp. has made an unsolicited bid for Athenahealth Inc. (ATHN) of $160 per share, or an estimated total value of over $6 billion, to take the company private. The price represents a premium of around 27% to Athena’s share price at Friday market close. Athena’s shares soared more than 20% after news of the bid was released.

Elliot has held a 9% stake in Athenahealth and has been trying to push for strategic changes at the company but said it was dissatisfied with Athena’s implementation of its plans as well as the overall performance. The changes included the appointment of a President to run operations. Elliot added that as long as Athena remained a public company, it would not be possible for it to make the necessary changes.

Elliot Management founder Paul Singer
Elliot Management founder Paul Singer (Image Courtesy: World Economic Forum/Wikimedia Commons)

Elliot said Athena has missed out in terms of outlook goals, product execution and creation of shareholder value. The fund also pointed out the lack of stability in the company’s leadership team. Athenahealth, which is led by Jonathan Bush, brought in former GE chief Jeff Immelt to take up the role of Chairman earlier this year, as part of a plan to separate the roles of CEO and Chairman.

Last year, Athena had rejected Elliot’s suggestion of going private. This time, however, Athena confirmed that it received an offer from Elliot and said its board would review it. The company has sought the advice of investment bank Lazard Ltd. and law firm Weil, Gotshal & Manges LLP.

Some analysts believe the offer price is low, given Athena’s margins and revenue profile while others feel the offer is good enough to provide value to shareholders.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top